Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 20 studies | 33% ± 11% | |
fibroblast | 20 studies | 29% ± 11% | |
astrocyte | 11 studies | 33% ± 18% | |
epithelial cell | 6 studies | 27% ± 12% | |
connective tissue cell | 6 studies | 30% ± 5% | |
pericyte | 5 studies | 18% ± 2% | |
endothelial cell | 5 studies | 23% ± 4% | |
Mueller cell | 5 studies | 42% ± 9% | |
hepatocyte | 5 studies | 47% ± 20% | |
adventitial cell | 4 studies | 22% ± 8% | |
goblet cell | 4 studies | 20% ± 4% | |
enterocyte | 3 studies | 18% ± 2% | |
myofibroblast cell | 3 studies | 27% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 20731.37 | 226 / 226 | 100% | 192.61 | 406 / 406 |
kidney | 100% | 4755.51 | 89 / 89 | 100% | 117.80 | 899 / 901 |
intestine | 100% | 4926.42 | 964 / 966 | 100% | 89.23 | 525 / 527 |
pancreas | 100% | 4177.48 | 328 / 328 | 98% | 80.11 | 174 / 178 |
ovary | 100% | 5832.07 | 180 / 180 | 98% | 50.01 | 420 / 430 |
stomach | 99% | 2649.00 | 354 / 359 | 99% | 83.47 | 283 / 286 |
esophagus | 98% | 3005.52 | 1413 / 1445 | 97% | 48.83 | 178 / 183 |
breast | 100% | 4448.95 | 458 / 459 | 95% | 38.03 | 1062 / 1118 |
bladder | 100% | 4280.95 | 21 / 21 | 92% | 53.21 | 464 / 504 |
thymus | 99% | 2774.36 | 644 / 653 | 93% | 36.12 | 564 / 605 |
uterus | 100% | 4984.96 | 170 / 170 | 88% | 44.86 | 405 / 459 |
prostate | 100% | 3472.87 | 244 / 245 | 88% | 24.69 | 444 / 502 |
adrenal gland | 100% | 8809.83 | 258 / 258 | 70% | 58.73 | 160 / 230 |
skin | 73% | 2583.33 | 1314 / 1809 | 91% | 86.76 | 430 / 472 |
lung | 82% | 1769.31 | 474 / 578 | 82% | 32.50 | 942 / 1155 |
brain | 64% | 1963.70 | 1702 / 2642 | 64% | 18.60 | 449 / 705 |
spleen | 100% | 5548.63 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.46 | 1 / 1 |
adipose | 100% | 5457.79 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 95% | 3116.59 | 821 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 41.06 | 73 / 80 |
tonsil | 0% | 0 | 0 / 0 | 80% | 20.90 | 36 / 45 |
lymph node | 0% | 0 | 0 / 0 | 66% | 14.33 | 19 / 29 |
blood vessel | 43% | 996.58 | 571 / 1335 | 0% | 0 | 0 / 0 |
muscle | 32% | 462.38 | 254 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 9% | 94.50 | 81 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
No associated gene sets found.
Gene name | OAF |
Protein name | Out at first protein homolog (HCV NS5A-transactivated protein 13 target protein 2) Out at first protein homolog |
Synonyms | NS5ATP13TP2 |
Description | |
Accessions | ENST00000531220.1 ENST00000328965.9 Q86UD1 E9PJ29 |